EID Parry (India) Ltd logo

EID Parry (India) Ltd

EIDPARRY NSE

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

AI Verdict: HOLD Confidence: 5%

EID Parry trades at an attractive PE of 9.1x with strong TTM sales growth of 22%, but declining profitability (-3% TTM profit growth), low ROE of 8% last year, and a sharp 26% stock correction in the past year warrant caution. The valuation is undemanding but fundamental momentum is weakening.

Key Fundamentals

MicrocapFertilizersChemicals
Market Cap
₹12,651 Cr
Volatility
Moderate
P/E Ratio
22.17
EBITDA
₹2,971 Cr
Return on Equity
14.43%
Debt to Equity
0.3
Book Value
₹492.6
EPS
₹49.62
52W High
₹1,246.8
52W Low
₹698.2

Technical Indicators

Key Insights

Weaknesses

3
  • Company has a low return on equity of 10.2% over last 3 years.
  • Dividend payout has been low at 4.71% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.10%

Growth Rate

Revenue Growth
20.54%
Net Income Growth
-25.75%
Cash Flow Change
-1.92%
ROE
-4.99%
ROCE
-0.25%
EBITDA Margin (Avg.)
-19.83%

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
HOLD
Risk medium

EID Parry trades at an attractive PE of 9.1x with strong TTM sales growth of 22%, but declining profitability (-3% TTM profit growth), low ROE of 8% last year, and a sharp 26% stock correction in the past year warrant caution. The valuation is undemanding but fundamental momentum is weakening.

Bull Case 7
  • Attractive valuation with PE of 9.1x, significantly below FMCG sector average of 40-50x, offering margin of safety
  • Strong TTM revenue growth of 22% indicates robust top-line momentum and demand recovery
  • Price-to-book of 1.43x is reasonable for a company with established sugar and nutraceuticals business
  • 10-year compounded profit CAGR of 36% demonstrates long-term earnings power and scalability
  • 5-year compounded sales CAGR of 16% shows consistent revenue compounding over medium term
  • 100% of analysts (1 out of 1) have a buy rating on the stock
  • Market cap of Rs 12,791 crore provides reasonable liquidity and mid-cap stability
Bear Case 8
  • Stock has declined 26% in the last 1 year, indicating significant negative price momentum
  • TTM profit growth is negative at -3%, showing margin compression despite strong revenue growth
  • 3-year compounded profit CAGR is -9%, reflecting sustained earnings deterioration
  • ROE has declined from 12% (5-year average) to just 8% last year, signaling weakening capital efficiency
  • Dividend payout is extremely low at 4.71% of profits over last 3 years, poor shareholder returns
  • Promoter holding has decreased by 3.10% over last 3 years, raising governance concerns
  • Dividend yield of only 0.57% offers minimal income support during periods of capital erosion
  • 3-year sales CAGR of just 3% suggests the recent 22% TTM growth may not be sustainable

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 14h ago
Headwinds 2
  • Q4 loss and refinery closure Jun 02

    Q4FY26 net loss of ₹33,330 lakh driven by exceptional items and ₹293 crore refinery loss. Company infusing ₹600 crore into PSRIPL to meet loan obligations by June 30, 2026.

  • FY26 profit sharply impacted Jun 02

    Consolidated FY26 net profit fell to ₹56,954 lakh as Q4 losses and refinery shutdown weighed on full-year results.

Positives 1
  • Pivot to higher-margin sweeteners Jun 02

    Management recalibrating CPG strategy towards higher-margin sweeteners and focusing on cost efficiency post-refinery exit.

Neutral 2
  • Trading window closed July 1 Jun 23

    EID Parry shuts trading window from July 1 until 48 hours after Q1FY27 results per SEBI insider trading regulations.

  • ₹62.71 Cr block trade on NSE Jun 09

    Approximately 865,136 shares traded in a single block at ₹724.90 per share, totalling ₹62.71 crores, suggesting institutional activity.

TL;DR: EID Parry faces near-term pain from the PSRIPL refinery closure, which drove a Q4 loss and requires a ₹600 crore cash infusion by end-June 2026. On the positive side, management is pivoting towards higher-margin sweeteners and tightening cost controls. Institutional block trade activity suggests continued large-investor engagement. The trend is stabilising but capital allocation pressure from the refinery wind-down remains a key risk into FY27.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
6,860
7,026
9,059
7,770
5,557
6,747
9,330
8,720
6,811
8,724
11,624
10,312
7,882
Expenses
6,245
6,363
8,006
7,358
5,098
6,279
8,372
8,027
6,298
7,918
10,427
9,477
7,271
Operating Profit
615
664
1,053
412
459
468
959
694
513
805
1,198
835
611
OPM %
9%
9%
12%
5%
8%
7%
10%
8%
8%
9%
10%
8%
8%
Other Income
5
-11
151
41
123
60
69
117
459
90
151
60
-430
Interest
87
82
74
53
86
84
94
99
96
104
129
103
119
Depreciation
105
94
101
112
113
117
123
130
142
176
158
204
226
PBT
428
477
1,029
288
382
327
811
582
735
615
1,062
588
-162
Tax %
33%
32%
24%
25%
23%
31%
27%
29%
27%
25%
28%
26%
77%
Net Profit
287
325
782
217
294
226
592
416
539
464
766
437
-287
EPS in Rs
10.08
6.13
25.48
6.66
12.41
5.14
17.21
10.97
16.12
13.85
23.86
13.05
-18.74
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
13,952
15,358
14,391
15,373
16,556
17,129
18,556
23,521
35,244
29,413
31,609
38,534
Expenses
12,938
14,517
12,965
14,068
15,105
15,242
16,467
21,146
32,088
26,825
28,975
35,085
Operating Profit
1,014
841
1,426
1,305
1,450
1,887
2,089
2,375
3,156
2,588
2,633
3,450
OPM %
7%
5%
10%
8%
9%
11%
11%
10%
9%
9%
8%
9%
Other Income
105
179
159
150
83
129
17
240
83
304
706
-129
Interest
420
451
417
336
425
430
236
152
298
295
372
454
Depreciation
244
250
248
251
272
319
332
334
376
421
512
763
PBT
455
319
920
868
837
1,266
1,539
2,129
2,564
2,175
2,455
2,103
Tax %
39%
45%
23%
40%
48%
30%
35%
26%
29%
26%
28%
34%
Net Profit
276
175
708
517
438
889
1,000
1,574
1,828
1,618
1,773
1,380
EPS in Rs
6.64
1.96
29.61
14.45
8.67
26.43
25.26
51.12
53.37
50.68
49.41
32.02
Div. Payout %
89%
0%
14%
21%
35%
0%
0%
22%
18%
8%
0%
6%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
18
18
18
18
18
18
18
18
18
18
18
18
Reserves
2,209
2,370
2,733
2,952
3,110
3,502
4,565
5,308
6,067
7,040
7,918
8,748
Borrowings
4,823
5,144
3,923
4,470
5,125
4,347
1,229
1,259
1,618
1,740
2,704
3,528
Other Liabilities
5,849
6,600
6,691
7,088
7,649
7,069
7,444
9,358
11,076
12,688
13,731
16,960
Total Liabilities
12,899
14,131
13,364
14,528
15,901
14,936
13,257
15,943
18,778
21,487
24,371
29,254
Fixed Assets
3,476
3,343
3,297
3,197
3,077
3,858
3,583
3,763
3,889
4,896
6,148
8,292
CWIP
75
77
39
54
203
85
206
160
486
520
422
304
Investments
369
688
569
430
418
413
453
563
609
1,275
1,453
2,477
Other Assets
8,979
10,022
9,459
10,847
12,203
10,579
9,014
11,456
13,794
14,796
16,348
18,181
Total Assets
12,899
14,131
13,364
14,528
15,901
14,936
13,257
15,943
18,778
21,487
24,371
29,254
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
222
437
1,969
259
-52
1,986
4,771
2,278
359
1,974
1,936
1,542
Investing
-307
-192
-148
13
-357
-282
-548
-1,732
487
-1,740
-2,783
-174
Financing
-142
-221
-1,842
42
34
-1,769
-3,598
-499
-184
-497
74
-551
Net Cash Flow
-227
23
-21
314
-375
-65
625
47
661
-263
-772
817
Free Cash Flow
35
233
1,839
82
-396
1,628
4,455
1,845
-370
1,051
1,323
5
CFO/OP
36
73
160
48
24
126
252
117
33
101
102
67
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
45
49
47
43
46
45
17
9
8
23
20
22
Inventory Days
138
124
127
134
175
131
112
111
81
112
101
107
Days Payable
141
145
170
174
172
141
124
114
84
121
113
116
Cash Conversion Cycle
42
27
4
3
49
35
6
6
5
14
8
13
Working Capital Days
-1
2
15
4
17
36
45
29
27
27
14
40
ROCE %
11%
9%
16%
16%
14%
18%
21%
26%
27%
20%
17%
18%

Shareholding Pattern

As of Mar 2026
Promoters 41.44%
Public 22.81%
DIIs 16.75%
FIIs 12.21%
Others 6.80%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
44.74%
44.74%
44.68%
44.66%
44.64%
44.61%
44.55%
44.55%
44.55%
44.51%
44.51%
42.23%
42.23%
42.23%
42.22%
41.69%
41.61%
41.54%
41.49%
41.44%
41.44%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
8.71%
8.85%
10.22%
10.66%
12.64%
12.17%
12.66%
12.77%
12.61%
12.21%
DIIs
2.31%
3.82%
4.23%
3.93%
4.12%
4.18%
4.23%
4.12%
4.92%
4.76%
4.22%
4.92%
11.87%
12.45%
13.29%
13.29%
13.83%
14.46%
15.57%
16.28%
16.75%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
34.12%
33.05%
33.51%
33.15%
32.75%
31.69%
29.17%
29.56%
29.47%
30.26%
31.68%
33.64%
28.85%
27.11%
26.31%
25.17%
25.15%
24.39%
23.27%
22.72%
22.81%
Others
18.83%
18.39%
17.58%
18.26%
18.48%
19.52%
22.05%
21.78%
21.06%
20.46%
19.59%
10.49%
8.20%
7.99%
7.52%
7.20%
7.24%
6.95%
6.90%
6.94%
6.80%
No. of Shareholders
58,101
68,369
72,531
69,729
75,303
76,121
78,194
82,503
79,937
88,142
1,07,640
1,08,246
1,07,011
1,18,928
1,26,722
1,26,023
1,25,719
1,18,705
1,19,631
1,13,020
1,12,286

Documents

Frequently Asked Questions about EID Parry (India) Ltd

What does EID Parry (India) Ltd do?
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]
Where is EID Parry (India) Ltd (EIDPARRY) listed?
EID Parry (India) Ltd is listed on the Indian stock exchanges. It is listed on NSE: EIDPARRY and BSE: 500125. You can view its live share price, financials, and ratios on Tapetide.
Which sector does EID Parry (India) Ltd belong to?
EID Parry (India) Ltd operates in the Fast Moving Consumer Goods sector within the Food Products industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of EID Parry (India) Ltd?
EID Parry (India) Ltd has a market capitalisation of approximately ₹12651.20 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of EID Parry (India) Ltd?
The Price-to-Earnings (PE) ratio of EID Parry (India) Ltd is 22.17. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of EID Parry (India) Ltd?
Over the past 52 weeks, EID Parry (India) Ltd has traded between a low of ₹698.2 and a high of ₹1,246.8. This range helps investors understand the stock's price volatility and recent trading levels.
Does EID Parry (India) Ltd pay dividends?
Yes, EID Parry (India) Ltd has a dividend yield of 0.56%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of EID Parry (India) Ltd?
EID Parry (India) Ltd has a Return on Equity (ROE) of 14.43%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research EID Parry (India) Ltd on Tapetide?
On Tapetide, you can view EID Parry (India) Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

Website eidparry.com
CEO Mr. Muthiah Murugappan
Employees 2,384
Listed 1995-05-10
Face Value ₹ 1
Issued Size 17,78,72,717

Explore More